Nurse Practitioner · Amherst, NY
NPI
1407413248
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3980 Sheridan Dr
Amherst, NY, 14226
Phone (716) 250-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
4,299 services
Medicare patients, 2024
293
Average age 69
Drug cost, 2024
$2.6M
8,253 prescriptions
Company payments, 2025
$4,358
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabila Shah was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 805 times for 31 patients. In total Sabila Shah billed 4,299 services in 20 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 805 | 31 | $0.07 | $56.89 |
| 99214 Office E&M - Established | Office | 356 | 251 | $71.94 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 273 | 201 | $9.92 | $2,708 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 149 | 60 | $40.43 | $6,024 |
| 96127 Behavioral Health Services | Office | 101 | 49 | $3.32 | $335 |
| 64450 Musculoskeletal | Office | 46 | 21 | $62.70 | $2,884 |
| 64405 Musculoskeletal | Office | 45 | 20 | $32.06 | $1,443 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 26 | 20 | $31.12 | $809 |
| 99215 Office E&M - Established | Office | 20 | 18 | $110.84 | $2,217 |
| 99213 Office E&M - Established | Office | 13 | 12 | $44.64 | $580 |
By year: 2022 $32K for 1,120 services; 2023 $37K for 1,838 services; 2024 $56K for 4,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sabila Shah prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,107 prescriptions and refills. In total Sabila Shah wrote 8,253 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,107 | 2,129 | 296 | $54K |
| Lamotrigine Generic | 769 | 1,328 | 203 | $11K |
| Gabapentin Generic | 673 | 1,100 | 188 | $11K |
| Primidone Generic | 531 | 1,051 | 142 | $14K |
| Trazodone Hcl Generic | 275 | 489 | 70 | $2,966 |
| Topiramate Generic | 265 | 472 | 59 | $3,087 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 235 | 550 | 70 | $6,560 |
| Sertraline Hcl Generic | 211 | 415 | 66 | $3,361 |
| Rasagiline Mesylate Generic | 201 | 506 | 64 | $53K |
| Pregabalin Generic | 181 | 191 | 48 | $4,211 |
| Escitalopram Oxalate Generic | 176 | 380 | 61 | $1,785 |
| Bupropion Xl Bupropion Hcl | 166 | 300 | 54 | $3,238 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 164 | 340 | 51 | $6,673 |
| Duloxetine Hcl Generic | 158 | 223 | 36 | $2,651 |
| Clonazepam Generic | 147 | 190 | 45 | $1,567 |
Brand drugs: 589 claims; generic drugs: 7,627 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabila Shah $4,358 ($4,358 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $1,049.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 58 | $1,049 |
| Abbott Laboratories ABT | 14 | $952 |
| Teva Pharmaceuticals USA, Inc. TEVA | 37 | $793 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $183 |
| Axsome Therapeutics, Inc. AXSM | 7 | $176 |
| LivaNova USA, Inc. LIVN | 3 | $159 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $139 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $121 |
| SK Life Science, Inc. | 4 | $96.23 |
| Lundbeck LLC | 5 | $96.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.